https://stanfordhealthcare.org/publications/477/477514.html
477514 | Stanford Health Care
A safety, tolerability, and pharmacokinetic analysis of two phase I studies of multitargeted small molecule tyrosine kinase inhibitor XL647 with an intermitte
stanfordhealthcare